33870-91-6 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
2-(benzylthio)-6-chloropyrazine is used as a key intermediate in the synthesis of pharmaceutical compounds for its unique chemical properties and potential biological activities. It aids in the development of new drugs and therapeutic agents, contributing to advancements in medicinal chemistry.
Used in Organic Synthesis:
In the field of organic synthesis, 2-(benzylthio)-6-chloropyrazine is utilized as a building block for the creation of various organic compounds. Its presence in the molecular structure allows for the formation of diverse chemical entities, expanding the scope of organic chemistry.
Used in Chemical Research:
2-(benzylthio)-6-chloropyrazine is employed as a subject of study in chemical research to explore its unique properties and potential applications. This research contributes to a deeper understanding of its role in chemical reactions and interactions, furthering the knowledge in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 33870-91-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,8,7 and 0 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 33870-91:
(7*3)+(6*3)+(5*8)+(4*7)+(3*0)+(2*9)+(1*1)=126
126 % 10 = 6
So 33870-91-6 is a valid CAS Registry Number.
33870-91-6Relevant academic research and scientific papers
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
-
Paragraph 00503, (2021/02/19)
This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.
2-AMINO-N-HETEROARYL-NICOTINAMIDES AS NAV1.8 INHIBITORS
-
Page/Page column 83, (2020/05/28)
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Nav1.8 channel activity and may be useful in the treatment, prevention, management, amelioration, control and suppression of diseases mediated by Nav1.8 channel activity. The compounds of the present invention may be useful in the treatment, prevention or management of pain disorders, cough disorders, acute itch disorders, and chronic itch disorders.
QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
-
Page/Page column 279-280, (2011/04/14)
A compound of formula (I) wherein A, X, Y, Z, R1 and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment and prevention of arrhythmia, IKur-associated disorders, and other disorders mediated by ion channel function.
